普雷加巴林在乳腺后重建中的抗效应:随机双盲研究
Rafael R Fernandes1, Marcello F Salgado-Filho2, Guilherme B Graziosi3
1From the Fluminense Federal University, Niterói, Rio de Janeiro, Brazil.
Plastic and reconstructive surgery. Global open
|October 27, 2025
概括
在接受乳房重建的患者中,普雷加巴林没有显著降低术后恶心和吐 (PONV). 这项研究发现,在pregabalin和安慰剂组之间,PONV发病率,疼痛或不良事件没有差异.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
背景情况:
- 手术后恶心和吐 (PONV) 是全身麻醉后的常见并发症.
- 普雷加巴林正在研究其减轻PONV发病率的潜力.
研究的目的:
- 评估pregabalin在手术后24小时内减少PONV的抗效果.
- 评估二次结果,包括疼痛,阿片类药物缓解效应和不良事件.
主要方法:
- 这是一项随机,双盲,安慰剂控制的研究,涉及52名接受腹痛后乳房重建的女性患者.
- 患者接受了75毫克的普雷加巴林两次或安慰剂,结果在术后24小时内进行评估.
主要成果:
- 在pregabalin和安慰剂组之间,在恶心或吐的发生率上没有观察到统计学上显著的差异.
- 普雷加巴林在减少术后疼痛,需要救援抗/止痛药,慢性疼痛发展或不良事件方面没有显著的益处.
结论:
- 在手术后24小时内服用普雷加巴林,在经过腹腔术后乳房重建的患者中没有显著降低PONV.
- 该研究没有支持在这种特定患者群体中使用普拉加巴林预防PONV.
更多相关视频
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
4.0K
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
806
相关概念视频
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.